Prestige Biologics Co., Ltd. (KOSDAQ:334970)

Revenue by Segment

Financials in millions KRW. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2019
Period Ending	Jun 30, 2024	Jun 30, 2023	Dec 31, 2021	Dec 31, 2019
Antibody Drugs	1.48B
Other than Service	689.62M

Revenue by Geography

Financials in millions KRW. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2019
Period Ending	Jun 30, 2024	Jun 30, 2023	Dec 31, 2021	Dec 31, 2019
South Korea	2.17B

Data Source: Finnhub Last updated: Mar 31, 2026

Financial data is provided by Finnhub and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 8, 2026

Data Sources Report a data error